161 related articles for article (PubMed ID: 21303949)
1. Growth hormone-dependent pathogenesis of human hepatic steatosis in a novel mouse model bearing a human hepatocyte-repopulated liver.
Tateno C; Kataoka M; Utoh R; Tachibana A; Itamoto T; Asahara T; Miya F; Tsunoda T; Yoshizato K
Endocrinology; 2011 Apr; 152(4):1479-91. PubMed ID: 21303949
[TBL] [Abstract][Full Text] [Related]
2. GH administration rescues fatty liver regeneration impairment by restoring GH/EGFR pathway deficiency.
Collin de l'Hortet A; Zerrad-Saadi A; Prip-Buus C; Fauveau V; Helmy N; Ziol M; Vons C; Billot K; Baud V; Gilgenkrantz H; Guidotti JE
Endocrinology; 2014 Jul; 155(7):2545-54. PubMed ID: 24708244
[TBL] [Abstract][Full Text] [Related]
3. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A
Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548
[TBL] [Abstract][Full Text] [Related]
4. GH-independent IGF-I action is essential to prevent the development of nonalcoholic steatohepatitis in a GH-deficient rat model.
Nishizawa H; Takahashi M; Fukuoka H; Iguchi G; Kitazawa R; Takahashi Y
Biochem Biophys Res Commun; 2012 Jun; 423(2):295-300. PubMed ID: 22659415
[TBL] [Abstract][Full Text] [Related]
5. A quantitative real-time RT-PCR assay for salmon IGF-I mRNA, and its application in the study of GH regulation of IGF-I gene expression in primary culture of salmon hepatocytes.
Pierce AL; Dickey JT; Larsen DA; Fukada H; Swanson P; Dickhoff WW
Gen Comp Endocrinol; 2004 Feb; 135(3):401-11. PubMed ID: 14723892
[TBL] [Abstract][Full Text] [Related]
6. GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism.
Barclay JL; Nelson CN; Ishikawa M; Murray LA; Kerr LM; McPhee TR; Powell EE; Waters MJ
Endocrinology; 2011 Jan; 152(1):181-92. PubMed ID: 21084450
[TBL] [Abstract][Full Text] [Related]
7. Human hepatoma HepaRG cell line engraftment in severe combined immunodeficient × beige mice using mouse-specific anti-Fas antibody.
Jiang L; Li JG; Lan L; Wang YM; Mao Q; You JP
Transplant Proc; 2010 Nov; 42(9):3773-8. PubMed ID: 21094855
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of insulin-like growth factor 1 attenuates aging-induced changes in hepatic function: role of autophagy.
Xu X; Hueckstaedt LK; Ren J
J Hepatol; 2013 Aug; 59(2):308-17. PubMed ID: 23583271
[TBL] [Abstract][Full Text] [Related]
9. GH enhances proliferation of human hepatocytes grafted into immunodeficient mice with damaged liver.
Masumoto N; Tateno C; Tachibana A; Utoh R; Morikawa Y; Shimada T; Momisako H; Itamoto T; Asahara T; Yoshizato K
J Endocrinol; 2007 Sep; 194(3):529-37. PubMed ID: 17761892
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone regulates the expression of hepatocyte nuclear factor-3 gamma and other liver-enriched transcription factors in the bovine liver.
Eleswarapu S; Jiang H
J Endocrinol; 2005 Jan; 184(1):95-105. PubMed ID: 15642787
[TBL] [Abstract][Full Text] [Related]
11. Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis.
López-Vicario C; González-Périz A; Rius B; Morán-Salvador E; García-Alonso V; Lozano JJ; Bataller R; Cofán M; Kang JX; Arroyo V; Clària J; Titos E
Gut; 2014 Feb; 63(2):344-55. PubMed ID: 23492103
[TBL] [Abstract][Full Text] [Related]
12. Rat hepatocyte insulin-like growth factor I and binding protein: effect of growth hormone in vitro and in vivo.
Scott CD; Martin JL; Baxter RC
Endocrinology; 1985 Mar; 116(3):1102-7. PubMed ID: 2982573
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit) mice and transgenic mice that overexpress bovine GH (bGH) or a bGH antagonist.
Iida K; Del Rincon JP; Kim DS; Itoh E; Nass R; Coschigano KT; Kopchick JJ; Thorner MO
Endocrinology; 2004 Apr; 145(4):1564-70. PubMed ID: 14726438
[TBL] [Abstract][Full Text] [Related]
14. Metabolic effects of reduced growth hormone action in fatty liver disease.
Rufinatscha K; Ress C; Folie S; Haas S; Salzmann K; Moser P; Dobner J; Weiss G; Iruzubieta P; Arias-Loste MT; Crespo J; Tilg H; Kaser S
Hepatol Int; 2018 Sep; 12(5):474-481. PubMed ID: 30206761
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture.
Thissen JP; Verniers J
Endocrinology; 1997 Mar; 138(3):1078-84. PubMed ID: 9048612
[TBL] [Abstract][Full Text] [Related]
16. Sexual dimorphism of rat liver gene expression: regulatory role of growth hormone revealed by deoxyribonucleic Acid microarray analysis.
Ahluwalia A; Clodfelter KH; Waxman DJ
Mol Endocrinol; 2004 Mar; 18(3):747-60. PubMed ID: 14684848
[TBL] [Abstract][Full Text] [Related]
17. Effects of growth hormone and insulin-like growth factor-1 on hepatocyte antioxidative enzymes.
Brown-Borg HM; Rakoczy SG; Romanick MA; Kennedy MA
Exp Biol Med (Maywood); 2002 Feb; 227(2):94-104. PubMed ID: 11815672
[TBL] [Abstract][Full Text] [Related]
18. GH directly inhibits steatosis and liver injury in a sex-dependent and IGF1-independent manner.
Sarmento-Cabral A; Del Rio-Moreno M; Vazquez-Borrego MC; Mahmood M; Gutierrez-Casado E; Pelke N; Guzman G; Subbaiah PV; Cordoba-Chacon J; Yakar S; Kineman RD
J Endocrinol; 2021 Jan; 248(1):31-44. PubMed ID: 33112796
[TBL] [Abstract][Full Text] [Related]
19. Hepatic PPARγ Is Not Essential for the Rapid Development of Steatosis After Loss of Hepatic GH Signaling, in Adult Male Mice.
Kineman RD; Majumdar N; Subbaiah PV; Cordoba-Chacon J
Endocrinology; 2016 May; 157(5):1728-35. PubMed ID: 26950202
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels.
Fusco A; Miele L; D'Uonnolo A; Forgione A; Riccardi L; Cefalo C; Barini A; Bianchi A; Giampietro A; Cimino V; Landolfi R; Grieco A; De Marinis L
Clin Endocrinol (Oxf); 2012 Oct; 77(4):531-6. PubMed ID: 22077984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
